Skip to main content
Apply for Grants

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

  • ${value}

Filter Results (1978${count})

  • Priority Biology, 2021
    Efficacy of PRKN Gene Delivery toward Mitigation of Alpha-synuclein-induced Degeneration

    Study Rationale:
    Genetic mutations that cause the functional loss of the PRKN gene and its corresponding protein, parkin, can cause early-onset Parkinson’s disease (PD). Regardless of the cause...

  • Therapeutic Pipeline Program, 2021
    Understand Me for Life: An Intelligibility App for Parkinson's Disease

    Study Rationale:
    Approximately 90% of people with Parkinson’s develop speech and language problems over the course of the disease, and more than half of these speakers experience problems with...

  • Research Grant, 2021
    Parkinson’s Disease Patient Report of Problems (PD-PROP) Curation

    Study Rationale:
    What people with Parkinson’s feel and experience about their disease, and how it affects their lives, is of paramount importance to their care and participation in research. The...

  • Priority Biology, 2021
    Studying the Properties of Alpha-Synuclein Aggregates Amplified from Human Cerebrospinal Fluid

    Study Rationale:
    Aggregates of the protein alpha-synuclein, which accumulate in the brains of people with Parkinson’s disease (PD), can also be detected in biofluids like cerebrospinal fluid (CSF)...

  • Research Grant, 2021
    Hypoxia (Limiting Oxygen Levels) as a Novel Treatment for Parkinson’s Disease

    Study Rationale:
    Many anecdotes suggest that people with Parkinson’s disease (PD) can experience a marked improvement in symptoms when they travel to the mountains or during flights at high altitude...

  • Target Advancement Program, 2021
    SCARB2 as a Potential Target in Parkinson’s Disease

    Study Rationale:
    Mutations in GBA, a gene that encodes an enzyme called glucocerebrosidase, are a common risk factor for Parkinson’s disease (PD). Inside cells, glucocerebrosidase must be escorted to...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.